Pharmacokinetics of intravenous amiodarone in patients with impaired left ventricular function

Journal of Clinical Pharmacology

Volumn 36, Issue 8, 1996, Pages 720-727

  Vadiei, Kiumars ^a   O'Rangers, Eleanor A ^b   Klamerus, Karen J ^a   Kluger, Jeffrey ^b   Kazierad, David J ^c   Leese, Philip T ^d   Chow, Moses S ^b   Zimmerman, James J ^a  

^a WYETH AYERST RESEARCH   (United States)

^b HARTFORD HOSPITAL   (United States)

^c Millard Fillmore Gates Hospital   (United States)

^d Innovex Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DRUG METABOLITE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INFUSION; FEMALE; HEART EJECTION FRACTION; HEART VENTRICLE FAILURE; HUMAN; MALE;

EID: 0029844852     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04241.x     Document Type: Article

References (27)

1. Greene HL: The efficacy of amiodarone in the treatment of ventricular tachycardia or ventricular fibrillation. Prog Cardiovasc Dis 1989;31:319-354.
2. Koean HA, Horowitz LN: Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrthythmias. Prog Cardiovasc Dis 1989;31:355-366.
3. Rakita L, Sobel SM: Amiodarone in the treatment of refractory ventricular arrhythmias. JAMA 1983;259:1293-1295.
4. Kaski JC, Girotti LA, Messuti H, Rutitzky B, Rosenbaum MB: Long-term management of sustained, recurrent symptomatic ventricular tachycardia with amiodarone. Circulation 1981;64:273-278.
5. Kadish AH, Marchlinski FE, Josephson ME, Buxton AE: Amiodarone: correlation of early and late electrophysiologic studies with outcome. Am Heart J 1986;112:1134-1140.
6. Holt DW, Tucker ET, Jackson PR, Storey GCA: Amiodarone pharmacokinetics. Am Heart J 1983;106:840-847.
7. Mostow ND, Rakita L, Vrobel TR, Noon D, Blumer J: Amiodarone: intravenous loading for rapid suppression of complex ventricular arrhythmias. J Am Coll Cardiol 1984;4:97-104.
8. Freedman MD, Somberg JC: Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol 1991;31:1061-1069.
9. Hohnloser SH, Meinertz T, Dammacher T, Steiert K, Jähnchen E, Zehender M, et al: Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. Am Heart J 1991;121:89-95.
10. Shammas FV, Dickstein K: Clinical pharmacokinetics in heart failure. Clin Pharmacokinet 1988;15:94-113.
11. Braunwald E: Assessment of cardiac function. In. Braunwald E (ed.): Heart Disease: A Textbook of Cardiovascular Medicine. Second edition. Philadelphia: WB Saunders, 1984;467-487.
12. Younis LT, Melin JA, Robert AR, Detry JMR: Influence of age and gender on left ventricular volumes and ejection fraction during upright exercise in normal subjects. Eur Heart J 1990;11:916-924.
13. DasGupta P, Ramhanmdany E, Bridgen G. : Improvement in left ventricular function after rapid weight loss in obesity. Eur Heart J 1992;13:1060-1066.
14. Aronow WS, Stein PD, Sabbah HN, Koenigsberg M: Resting left ventricular ejection fraction in elderly patients without evidence of heart disease. Am J Cardiol 1989;63:368-369.
15. Storey GCA, Holt DW: High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in plasma or serum at the concentrations attained following a single 400-mg dose. J Chromatogr 1982;245:377-380.
16. Gibaldi M, Perrier D: Pharmacokinetics. Second edition. New York: Marcel Dekker, 1982.
17. Houston JB: Kinetics of drug metabolism and disposition: physiological determinants. In. Rawlins MD, Wilkinson GR (eds.): Clinical Pharmacology and Therapeutics. Volume 2: Drug Metabolism and Disposition, Considerations in Clinical Pharmacology. London: MTP Press Limited, 1985;63-90.
18. SAS Institute: SAS User's Guide: Statistics. Cary, NC: SAS Institute, 1985.
19. Holt DW, Tucker ET, Jackson PR, Storey GCA: Amiodarone pharmacokinetics. Am Heart J 1983;106:840-847.
20. Berdeaux A, Roche A, Labaille T, Giroux B, Giudicelli JF: Tissue extraction of amiodarone and N-desthylamiodarone in man after a single oral dose. Br J Clin Pharmacol 1984;18:759-763.
21. Medical Economics Data: Cordorone (intravenous). In. Physicians' Desk Reference. Montvale, NJ: Medical Economics Data Production, 1996;2175.
22. Pollak PT, Sharma AD, Carruthers SG: Correlation of amiodarone dosage, heart rate. QT interval and corneal microdeposits with serum amiodarone and desethylamiodarone concentrations. Am J Cardiol 1989;64:1138-1143.
23. Brown AK, Holt DW, Anderson V: A practical regimen for intravenous amiodarone. Br J Clin Pract 1986;40:135-138.
24. Saksena S, Rothbart ST, Shah Y, Capello G: Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia. Am J Cardiol 1984;54:347-352.
25. Mooss AN, Mohiuddin SM, Hee TT, Esterbrooks DJ, Hilleman DE, Rovang KS, Sketch, Sr, MH: Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia. Am J Cardiol 1990;65:609-614.
26. Helmy I, Herre JM, Gee G, Sharkey H, Malone P, Sauve MJ, et al: Use of intravenous amiodarone for emergency treatment of life-threatening arrhythmias. J Am Coll Cardiol 1988;12:1015-1022.
27. Ochi RP, Goldenberg IF, Almquist A, Pritzker M, Mitstein S, Pedersen W, et al: Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in clinically ill patients with coronary artery disease. Am J Cardiol 1989;64:599-603.